MYCN and neuroblastoma: Recently, Henssen et al. showed that BRD4 specifically occupies N-Myc targets and other genes associated with super-enhancers, and that OTX015 specifically disrupts BRD4 binding to chromatin in NB MYCN-driven murine models, leading to significant survival advantage compared with untreated controls (Table 2) [101].